Phase IB Trial of the Anti-Cancer Stem Cell DLL4-Binding Agent Demcizumab with Pemetrexed and Carboplatin as First-Line Treatment of Metastatic Non-Squamous NSCLC

Mark J. McKeage, Dusan Kotasek, Ben Markman, Manuel Hidalgo, Michael J. Millward, Michael B. Jameson, Dean L. Harris, Robert J. Stagg, Ann M. Kapoun, Lu Xu, Brett G. M. Hughes

Research output: Contribution to journalArticlepeer-review

37 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase IB Trial of the Anti-Cancer Stem Cell DLL4-Binding Agent Demcizumab with Pemetrexed and Carboplatin as First-Line Treatment of Metastatic Non-Squamous NSCLC'. Together they form a unique fingerprint.

Agricultural and Biological Sciences

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science